期刊文献+

血小板反应蛋白1在2型糖尿病患者视网膜病变中的临床意义 被引量:7

Clinical value of thrombospondin-1 in patients with type 2 diabetic retinopathy
原文传递
导出
摘要 目的探讨血清血小板反应蛋白1(TSP-1)在DR患者中的水平变化及临床意义。方法选取120例研究对象,分为T2DM组(T2DM,n=31)、T2DM合并背景期视网膜病变组(T2DM+背景期视网膜病变,n=31)、T2DM合并增殖期视网膜病变组(T2DM+增殖期视网膜病变,n=29)及正常对照组(NC,n=29)。检测各组TSP-1、FPG、FIns、HbA1c、血脂、纤维蛋白原(Fib)等指标。结果各组血清TSP-1水平[(261.12±38.11)vs(284.66±38.74)vs(329.26±37.81)vs(121.60±10.78)ng/ml,P<0.01]比较差异有统计学意义。Pearson相关性分析显示,TSP-1与FPG、FIns、HbA1c、TC、LDL-C、Fib呈正相关,与HDL-C呈负相关。Logistic多元逐步回归分析显示,FIns、HbA1c、LDL-C、Fib是TSP-1的独立影响因素(t=4.182、6.054、-2.097、3.943,P<0.05或P<0.01)。血清TSP-1与Fib是DR发生的危险因素(t=-5.484、3.208,P<0.01)。结论 TSP-1与DR的发生发展关系密切,是DR的危险因素。 Objective To investigate the changes and clinical significance of thrombospondin-1 (TSP- 1) in patients with type 2 diabetic retinopathy. Methods A total of 120 patients were enrolled in this study and divided into four groups.. T2DM group(T2DM, n = 31), T2DM combined with background retinopathy (T2DM±background retinopathy, n = 31), T2DM group with proliferative retinopathy (T2DM+ proliferative retinopathy, n=29) and normal controls (NC, n= 29). TSP-1, FPG, Fins, HbA1 c, blood lipid and fibrinogen (Fib) were detected in each group. Results There was significant difference in serum TSP-1 level in the four groups[(261.12±38.11) vs (284.66±38.74) vs (329.26±37.81) vs (121.60±10.78) ng/ml, P 〈 0. 01]. Pearson correlation analysis showed that TSP-1 was positively correlated with FPG, Fins, HbA1 c, TC, LDL-C and Fib, while negatively correlated with HDL-C. Multiple linear regression analysis showed that Fins, HbA1 c, LDL-C and Fib were independent influencing factors for serum TSP-1 (t =4. 182, 6. 054, - 2. 097, 3. 943). TSP-1 and Fib were risk factors for diabetic retinopathy (DR)(t=-5. 484,3. 208, P〈0.01]. Conclusion TSP-1 might play a role in the occurrence and progression of DR. It was a risk factor for DR.
出处 《中国糖尿病杂志》 CAS CSCD 北大核心 2017年第8期703-706,共4页 Chinese Journal of Diabetes
基金 河北省2016年度医学科学研究重点课题计划(20160006)
关键词 血小板反应蛋白1 糖尿病 2型 糖尿病视网膜病变 纤维蛋白原 血脂 Thrombospondin-1 Diabetes mellitus, type 2 Diabetic retinopathy Fibrinogen Blood lipid
  • 相关文献

参考文献5

二级参考文献58

  • 1潘长玉,主译.Joslin糖尿病学[M].北京:人民卫生出版社,2007.1089.
  • 2Bhatt DK, Topol EJ. Antiplatelet and anticoagulant therapy in the secondary prevention of ischemic heart disease [ J]. Med Clin North Am, 2000,84(1) : 163 - 180
  • 3Griesshammer M, Beneke H, Nussbaumer B, et al. Increased platelet surface expression of p-selection and thrombespondin as markers of platelet avtviation in essential thrombocythaemia [ J ]. Thrombosis Res, 1999,46 (2) :191 - 196
  • 4Omoto S, Nomura S, Shouzu A, et al. Significance of platelet-derived micrpcerticles and activated platelets in diabetic nephropathy[J]. Eur J Clin Invest ,2004,34(3) :205 - 209
  • 5Elbl N, Krugluger W, Steit G, et al. Improve metabolic control decreases platelet activation markers in patients with type-2 diabetes [J]. Thromb Res,2003,10(4) :203 - 208
  • 6Zhao XM;Hu Y;Miller GG.Association of thrombospondin-1 and cardiac allograft vasculopathy in human cardiac allografts,2001(04).
  • 7Agah A;Kyriakides TR;Lawler J.The lack of thrombospondin-1(TSP1) dictates the course of wound healing in double-TSP1/TSP2-null mice,2002(03).
  • 8Stenina OI;Desai SY;Krukovets I.Thrombospondin-4 and its variants:expression and differential effects on endothelial cells[J],2003(12).
  • 9Isenberg JS;Ridnour LA;Perruccio EM.Thrombospondin-1 inhibits endothelial cell responses to nitric oxide in a cGMP-dependent manner[J],2005(37).
  • 10Agbanyo FR;Sixma JJ;de Groot GP.Thrombospondin-platelet interactions.Role of divalent cations,wall shear rate,and platelet membrane glycoproteins[J],1993(01).

共引文献19

同被引文献86

引证文献7

二级引证文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部